Literature DB >> 23576657

Fever of unknown origin and pancytopenia caused by culture-proven delayed onset disseminated bacillus Calmette-Guerin (BCG) infection after intravesical instillation.

Pedro Dammert1, Ziad Boujaoude, William Rafferty, Jonathan Kass.   

Abstract

A 78-year-old man was diagnosed with bladder carcinoma in situ and was successfully treated with intravesical bacillus Calmette-Guérin (BCG) instillations. At 6 months after the last dose, he developed fever, weight loss and malaise. He had an extensive negative workup at an outside hospital and was treated empirically with ciprofloxacin for 2 weeks. The fever resolved but returned months later and he was readmitted with pancytopenia, elevated alkaline phosphatase and ground glass opacities on the chest CT. Bone marrow and liver biopsies showed non-caseating granulomas and were negative for acid-fast bacillus (AFB) and fungal stains. Mycobacterium tuberculosis complex PCR of the bone marrow was negative. Owing to the high clinical suspicion of disseminated BCG infection, the patient was treated empirically. After 9 weeks of incubation, the bone marrow AFB culture grew Mycobacterium bovis. Within 2 months of treatment his symptoms resolved and his laboratory results normalised.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23576657      PMCID: PMC3645807          DOI: 10.1136/bcr-2013-008949

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  22 in total

1.  Disseminated infection after bacille Calmette-Guérin instillation for treatment of bladder carcinoma.

Authors:  J F Viallard; D Denis; J Texier-Maugein; M Parrens; I Faure; J L Pellegrin; B Leng
Journal:  Clin Infect Dis       Date:  1999-08       Impact factor: 9.079

2.  Vascular and other serious infections with Mycobacterium bovis after bacillus of Calmette-Guérin therapy for bladder cancer.

Authors:  W C Hellinger; W A Oldenburg; S Alvarez
Journal:  South Med J       Date:  1995-12       Impact factor: 0.954

3.  A case of BCG sepsis with bone marrow and liver involvement after intravesical BCG instillation.

Authors:  B Dederke; E O Riecken; T Weinke
Journal:  Infection       Date:  1998 Jan-Feb       Impact factor: 3.553

4.  Long-term results of intravesical bacillus Calmette-Guérin therapy for stage T1 superficial bladder cancer.

Authors:  M Brake; H Loertzer; R Horsch; H Keller
Journal:  Urology       Date:  2000-05       Impact factor: 2.649

Review 5.  Efficacy and safety of bacille Calmette-Guérin immunotherapy in superficial bladder cancer.

Authors:  D L Lamm
Journal:  Clin Infect Dis       Date:  2000-09       Impact factor: 9.079

6.  [Disseminated BCG infection in patients with urinary bladder carcinoma].

Authors:  Milos Korać; Branko Milosević; Lidija Lavadinović; Aleksandar Janjić; Branko Brmbolić
Journal:  Med Pregl       Date:  2009 Nov-Dec

7.  Miliary lung disease after intravesical bacillus Calmette-Guérin immunotherapy.

Authors:  R M Jasmer; M J McCowin; W R Webb
Journal:  Radiology       Date:  1996-10       Impact factor: 11.105

8.  [Sepsis and multiple organ failure after BCG-instillation for bladder cancer].

Authors:  A Elmer; U Bermes; L Drath; E Büscher; A Viertel
Journal:  Internist (Berl)       Date:  2004-08       Impact factor: 0.743

9.  Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer.

Authors:  D L Lamm; P M van der Meijden; A Morales; S A Brosman; W J Catalona; H W Herr; M S Soloway; A Steg; F M Debruyne
Journal:  J Urol       Date:  1992-03       Impact factor: 7.450

10.  Bone marrow infection with bacillus Calmette-Guérin (BCG) after intravesical immunotherapy.

Authors:  Johannes Nemeth; Brigitte Stoiser; Heide-Maria Winkler; Leonard Müllauer; Wolfgang Graninger; Stefan Winkler
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

View more
  6 in total

1.  Ocular tuberculosis in a calf.

Authors:  Jacobo Carrisoza-Urbina; Mario A Bedolla-Alva; Mireya Juárez-Ramírez; José A Gutiérrez-Pabello
Journal:  BMC Vet Res       Date:  2021-05-08       Impact factor: 2.741

Review 2.  How to optimally manage elderly bladder cancer patients?

Authors:  Francesco Soria; Marco Moschini; Stephan Korn; Shahrokh F Shariat
Journal:  Transl Androl Urol       Date:  2016-10

Review 3.  Bacillus Calmette-Guérin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literature.

Authors:  María Asunción Pérez-Jacoiste Asín; Mario Fernández-Ruiz; Francisco López-Medrano; Carlos Lumbreras; Ángel Tejido; Rafael San Juan; Ana Arrebola-Pajares; Manuel Lizasoain; Santiago Prieto; José María Aguado
Journal:  Medicine (Baltimore)       Date:  2014-10       Impact factor: 1.889

4.  Mycotic Aneurysm after Bacillus Calmette-Guérin Treatment: Case Report and Review of the Literature.

Authors:  Nathaniel D Coddington; Jesse K Sandberg; Chen Yang; Jennifer K Sehn; Eric H Kim; Seth A Strope
Journal:  Case Rep Urol       Date:  2017-02-20

5.  Transitory Spontaneous Remission of Myelodysplasia in an Elderly Man while Receiving Intravesical Bacillus Calmette-Guérin for Bladder Cancer: A Case Report and Review of the Literature.

Authors:  Nigel P Murray; Cynthia Fuentealba; Isidora Salazar; Aníbal Salazar; Marco Antonio Lopez; Simona Minzer
Journal:  Case Rep Hematol       Date:  2018-11-11

6.  Systemic BCGosis following intra-renal instillation of BCG: a case report.

Authors:  Jessica Schembri Higgans; Keith Pace; John Sciberras; Warren Scicluna
Journal:  J Surg Case Rep       Date:  2021-12-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.